Skip to main content

Table 6 Lifetime costs (US$), effectiveness and ICERs in alternative scenario

From: The cost-effectiveness of Antiretroviral Treatment in Khayelitsha, South Africa – a primary data analysis

Treatment option Lifetime costs Outcomes ICER
   Life Years QALYs Life Years QALYs
Undiscounted
Generalized No-ART 1,813 2.3 1.6   
Generalized ART 9,474 9.7 8.1 1,035 1,184
Discounted
Generalized No-ART 1,706 2.1 1.5   
Generalized ART 7,215 7.6 6.3 1,016 1,148